Lingohr & Partner Asset Management Gmb H Jazz Pharmaceuticals PLC Transaction History

Lingohr & Partner Asset Management Gmb H

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$129.64 - $160.7 $380,493 - $471,654	-2,935 Closed	0 $0
Q2 2021 Aug 10, 2021	SELL	$160.2 - $186.42 $176,220 - $205,062	-1,100 Reduced 27.26%	2,935 $521,000
Q1 2021 May 11, 2021	BUY	$150.19 - $173.5 $285,361 - $329,650	1,900 Added 88.99%	4,035 $663,000
Q3 2020 Nov 06, 2020	SELL	$105.46 - $144.13 $101,768 - $139,085	-965 Reduced 31.13%	2,135 $304,000
Q1 2020 May 07, 2020	SELL	$87.74 - $152.74 $417,291 - $726,431	-4,756 Reduced 60.54%	3,100 $309,000
Q4 2019 Feb 10, 2020	BUY	$117.65 - $153.73 $70,590 - $92,238	600 Added 8.27%	7,856 $1.17 Million
Q3 2019 Nov 15, 2019	BUY	$125.18 - $143.24 $388,058 - $444,044	3,100 Added 74.59%	7,256 $930,000
Q2 2019 Aug 14, 2019	BUY	$125.55 - $144.48 $521,785 - $600,458	4,156 New	4,156 $592,000

513

57.7M

188K

133K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.63B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of Lingohr & Partner Asset Management Gmb H, based on Form 13F filings with the SEC.

Stay updated on Lingohr & Partner Asset Management Gmb H with notifications on news.